Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Charles River Laboratories Intl (NY: CRL ) 221.61 -3.14 (-1.40%) Official Closing Price Updated: 7:00 PM EDT, May 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 927,644 Open 225.29 Bid (Size) 208.21 (1) Ask (Size) 228.72 (1) Prev. Close 224.75 Today's Range 220.37 - 225.29 52wk Range 161.65 - 275.00 Shares Outstanding 50,396,622 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News The Analyst Landscape: 7 Takes On Charles River May 10, 2024 Via Benzinga CRL Stock Earnings: Charles River Beats EPS, Beats Revenue for Q1 2024 May 09, 2024 CRL stock results show that Charles River beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Performance YTD -5.40% -5.40% 1 Month -3.69% -3.69% 3 Month -9.53% -9.53% 6 Month +17.23% +17.23% 1 Year +11.22% +11.22% More News Read More Charles River Laboratories Announces First-Quarter 2024 Results May 09, 2024 From Charles River Laboratories International, Inc. Via Business Wire The 7 Best Growth Stocks to Buy in May 2024 May 08, 2024 Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session May 07, 2024 Via Benzinga Evaluating Charles River: Insights From 7 Financial Analysts March 18, 2024 Via Benzinga Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP May 02, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally April 22, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing April 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call April 12, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology April 11, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics April 09, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River to Perform Plasmid Production for Ship of Theseus April 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm April 02, 2024 From Bragar Eagel & Squire Via GlobeNewswire Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 April 01, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Publishes 2023 Corporate Citizenship Report March 27, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine March 21, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration March 14, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at Barclays Global Healthcare Conference March 12, 2024 From Charles River Laboratories International, Inc. Via Business Wire The Top 3 Healthcare Stocks to Buy in March 2024 March 07, 2024 Via InvestorPlace Betting on Bitcoin: Does Coinbase Stock’s Surge Signal a Buy? March 07, 2024 Via InvestorPlace Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months March 06, 2024 Via Investor's Business Daily Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing February 21, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells February 20, 2024 From Charles River Laboratories International, Inc. Via Business Wire The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore. February 15, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
